460 — Sihuan Pharmaceutical Holdings Income Statement
0.000.00%
Last trade - 00:00- HK$4.85bn
- HK$2.16bn
- CNY1.86bn
- 12
- 57
- 30
- 19
Annual income statement for Sihuan Pharmaceutical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,878 | 2,464 | 3,038 | 2,181 | 1,861 |
| Cost of Revenue | |||||
| Gross Profit | 2,289 | 1,914 | 2,430 | 1,488 | 1,296 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5,285 | 1,677 | 2,266 | 4,012 | 1,699 |
| Operating Profit | -2,406 | 787 | 772 | -1,831 | 162 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2,423 | 766 | 496 | -2,123 | -161 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,713 | 547 | 243 | -2,320 | -258 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2,753 | 473 | 417 | -1,915 | -54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,753 | 473 | 417 | -1,915 | -54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.014 | 0.042 | 0.048 | -0.101 | -0.008 |
| Dividends per Share | |||||
| Special Dividends per Share |